Recently unlocked door: a fresh permission, approval, or qualification is already producing first real business
The model's full reasoning — Q2 2021 call → NO我们根据提供的财报电话会议记录,判断管理层是否描述了公司最近获得了某种权限、批准、资格、认证、上市或访问权,且该权利是之前没有的,并且已经开始了实际业务,且大部分潜力尚未实现。 在记录中,管理层提到了多个新进展,例如: - 获得新影院租赁(如The Grove和Americana at Brand),但这是租赁,不是权限。 - 接受比特币、Apple Pay、Google Pay作为支付方式,这是新能力,但属于公司自身系统升级,不是外部授予的权限。 - 与Warner Brothers达成协议,获得45天独家窗口,这是合作协议,但属于商业安排,不是外部权限。 - 提到AMC Investor Connect,但这是会员计划。 关键点:是否有“外部权威、客户、合作伙伴或机构授予的、以前没有的、允许公司销售、服务或运营的权限”?例如,监管批准、客户资格、认证、许可等。 在记录中,管理层提到“we just reached a formal agreement with our friends at Warner Brothers to show all of their movies in calendar year '22 respecting an exclusive theatrical window of 45 days”,这是与华纳兄弟的协议,但这是商业合同,不是外部授予的权限。另外,提到“we are hereby formally announcing on this call that by year-end, we will have the information technology systems in place to accept Bitcoin as payment”,这是公司自身计划,尚未实现。 没有提到任何监管批准、认证或许可。因此,不符合“最近获得权限”的条件。 此外,即使有,也没有提到“第一笔业务已经开始”和“大部分潜力尚未实现”的具体描述。 因此,答案应为NO。
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| DXCM | DexCom, Inc. | Q4 2023 | 2024-02-08 | B+ |
| RDCM | RADCOM Ltd. | Q4 2023 | 2024-01-31 | A |
| PFE | Pfizer Inc. | Q4 2023 | 2024-01-30 | F |
| NVAX | Novavax, Inc. | Q3 2023 | 2023-11-09 | F |
| RVLV | Revolve Group, Inc. | Q3 2023 | 2023-11-01 | C |
| APPS | Digital Turbine, Inc. | Q1 2024 | 2023-08-08 | D |
| SIBN | SI-BONE, Inc. | Q3 2022 | 2022-11-07 | C+ |
| HBB | Hamilton Beach Brands Holding Company | Q3 2022 | 2022-11-05 | C |
| CMLS | Cumulus Media Inc. | Q3 2022 | 2022-10-28 | D |
| YMM | Full Truck Alliance Co. Ltd. | Q2 2022 | 2022-08-25 | C+ |
| CDXC | ChromaDex Corporation | Q4 2021 | 2022-03-09 | C+ |
| VNDA | Vanda Pharmaceuticals Inc. | Q4 2021 | 2022-02-23 | F |
| AGIO | Agios Pharmaceuticals, Inc. | Q3 2018 | 2018-11-01 | C |
| AMGN | Amgen Inc. | Q3 2018 | 2018-10-30 | B+ |
| MAS | Masco Corporation | Q3 2018 | 2018-10-30 | C |
| PRIM | Primoris Services Corporation | Q2 2018 | 2018-08-11 | C+ |
| ATI | Allegheny Technologies Incorporated | Q1 2018 | 2018-04-24 | B |
| HOLX | Hologic, Inc. | Q4 2017 | 2017-11-08 | D |
| BIIB | Biogen Inc. | Q2 2017 | 2017-07-25 | B |
| CNS | Cohen & Steers, Inc. | Q2 2017 | 2017-07-20 | B |
| IONS | Ionis Pharmaceuticals, Inc. | Q1 2017 | 2017-05-09 | C |
| PDCO | Patterson Companies, Inc. | Q3 2017 | 2017-02-23 | C |
| BMY | Bristol-Myers Squibb Company | Q4 2016 | 2017-01-26 | F |
| MAT | Mattel, Inc. | Q3 2016 | 2016-10-19 | C |
NVAX · Q3 2023 → YESThe question is: Does management describe that the company RECENTLY OBTAINED A PERMISSION, APPROVAL, QUALIFICATION, CERTIFICATION, LISTING, OR ACCESS RIGHT it did not previously hold — something grant...NO The transcript describes shipments of the updated COVID vaccine that began three weeks ago in the US after competitor launches, along with EU approval in October. However, these details do not meet the criteria for a YES answer because the transcript does not explicitly frame this as a newly obtained permission or access right that the company did not previously hold. Instead, it presents the launch as an update to their existing COVID-19 vaccine platform, with references to prior versions and the ability to update for seasonal strains.
MAT · Q3 2016 → YESThe question is about whether management describes that the company recently obtained a permission, approval, etc., that it didn't previously hold, and that real first business through that newly open...YES The transcript shows management describing a recent new partnership with Toys "R" Us for American Girl, granting exclusive store-within-store access that previously excluded the company. Initial shipping began in the first full quarter, with the distribution build still in early stages and most of the market potential ahead.
MAS · Q3 2018 → YESThe question is about whether management describes that the company recently obtained a permission, approval, etc., that it didn't previously hold, and that real first business through that newly open...YES The transcript shows management describing a recent program access at Menards that enables sales of stock cabinetry, with initial performance already underway and ramping toward an $80 million annual run rate in Q4—indicating the door is newly open and most of the potential volume remains ahead.